Ken Griffin’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Ken Griffin’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$5.7K	–	14739
2025 Q1	$5.7K	Hold	200	–	–	﹤0.01%	13800
2024 Q4	$6.61K	Buy	+200	New	+$7.55K	﹤0.01%	13787
2024 Q2	–	Sell	-2,000	Closed	-$71.5K	–	15249
2024 Q1	$71.5K	Sell	2,000 -2,000	-50%	-$69.3K	﹤0.01%	11792
2023 Q4	$132K	Hold	4,000	–	–	﹤0.01%	10585
2023 Q3	$109K	Buy	4,000 +2,800	+233%	+$84.3K	﹤0.01%	10783
2023 Q2	$37.9K	Sell	1,200 -800	-40%	-$24.8K	﹤0.01%	12115
2023 Q1	$54.4K	Sell	2,000 -400	-17%	-$12.1K	﹤0.01%	12048
2022 Q4	$72.9K	Buy	+2,400	New	+$72.2K	﹤0.01%	11651
2021 Q1	–	Sell	-6,300	Closed	-$323K	–	13655
2020 Q4	$323K	Buy	+6,300	New	+$300K	﹤0.01%	8944
2019 Q2	–	Sell	-7,900	Closed	-$286K	–	9759
2019 Q1	$286K	Buy	+7,900	New	+$264K	﹤0.01%	7689
2018 Q4	–	Sell	-5,300	Closed	-$209K	–	9669
2018 Q3	$209K	Buy	+5,300	New	+$201K	﹤0.01%	8151

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Ken Griffin's SBIO Position: Q1 2026 in Review

Ken Griffin increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 97% in Q1 2026, buying an estimated $443K and bringing the position to 17,680 shares worth $925K. The position accounts for ﹤0.01% of the portfolio, ranked #7833.

Ken Griffin first reported a position in SBIO in Q3 2015 and has held it in 34 quarters since. The position peaked at $3.14M in Q4 2018. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Ken Griffin held 17,680 shares of ALPS Medical Breakthroughs ETF worth $925K as of Q1 2026.
Ken Griffin bought 8,702 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $443K.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #7833 holding.
Ken Griffin first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and has held it in 34 quarters since.
Ken Griffin's ALPS Medical Breakthroughs ETF position peaked at $3.14M in Q4 2018.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.